Back to News
Market Impact: 0.35

Notable Tuesday Option Activity: CPRI, HIMS, NVT

HIMSNVTCPRIMCKNDAQ
Futures & OptionsDerivatives & VolatilityMarket Technicals & FlowsInvestor Sentiment & PositioningHealthcare & Biotech
Notable Tuesday Option Activity: CPRI, HIMS, NVT

Hims & Hers (HIMS) saw 126,180 option contracts trade today (≈12.6M underlying shares), equal to roughly 74.2% of its one‑month average daily share volume (17.0M), led by 7,458 contracts in the $24 put expiring Feb. 13, 2026 (≈745,800 shares). nVent Electric (NVT) logged 12,700 contracts (≈1.3M underlying shares), about 66.3% of its one‑month average daily volume (1.9M), led by 2,177 contracts in the $130 call expiring Feb. 20, 2026 (≈217,700 shares). The oversized options flows could reflect concentrated directional bets or hedging activity and may increase near‑term volatility and liquidity considerations for the two names.

Analysis

Market structure: The HIMS flow (126,180 contracts ≈12.6M shares, ~74% of 1‑month ADV) is a concentrated demand for downside protection at the $24 Feb‑13‑2026 put, which will skew implied volatility and force delta‑hedging selling into the tape in the near term. Winners are active short/vol sellers and market‑makers who can collect premium or press shares lower via hedging; losers are long retail and liquidity providers if delta‑hedging is sustained. NVT’s concentrated $130 Feb‑20‑2026 call flow (~2,177 contracts) implies directional bullishness or event/speculation, tightening implied skew the other way for that single name. Risk assessment: Tail risks for HIMS include regulatory/reimbursement shocks, data/privacy litigation, or a negative earnings revision that could turn concentrated put demand into a cascade; these are low‑probability but >3x downside gamma events if realized. Timeframes: expect immediate (days) IV and price action; months to Feb‑2026 for option expiries to resolve; quarters for fundamental re‑rating. Hidden dependency: large institutional collars or convertible hedges can masquerade as directional puts — confirm block trade prints and SEC 13F/insider activity; catalysts are earnings, FDA/legislative updates, and any secondary offering announcements. Trade implications: For HIMS, avoid naked long equity; if you want exposure, prefer a defined‑risk short via buying the Feb‑13‑2026 $24 put or, better, sell a calendar/IV‑rich retire spread: sell Mar‑2026 puts vs buy Feb‑2026 $24 put to monetize term premium (size 1% portfolio). For NVT, favored direction is bullish: establish a 2–3% position via Feb‑20‑2026 130/150 bull‑call spread (caps cost and width). Pair trade: long NVT bull spread vs short HIMS put spread (1:1 notional) to express industrial vs telehealth dispersion. Contrarian angles: The market may be misreading protective/portfolio hedges as pure directional bets — if HIMS IV >80% or a 3‑day average price doesn’t breach $22, consider fading puts and selling premium. Historical parallels show heavy put flows often precede secondary offerings or hedges rather than outright collapses; fading vol is attractive but requires strict stop (e.g., widen >30% IV or >10% price move). Unintended consequence: aggressive premium selling can be blown out by a single regulatory or earnings surprise, so keep trades size‑limited and hedged.